期刊文献+

视神经脊髓炎的视觉诱发电位临床分析 被引量:2

Clinical analysis of visual evoked potential in neuromyelitis optica
下载PDF
导出
摘要 目的:探讨视觉诱发电位(VEP)在视神经脊髓炎(NMO)和复发性长节段横贯性脊髓炎(r-LETM)诊断中的应用价值。方法:对16例NMO和15例r-LETM住院患者进行VEP检测,并与正常组对照。结果:NMO组:与正常组P100比较,潜伏期显著延长(P<0.05),波幅显著降低(P<0.05);潜伏期异常率高于波幅异常率。r-LETM组:与正常组P100比较,潜伏期差异无显著性(P>0.05),波幅显著降低(P<0.05);波幅异常率高于潜伏期异常率。两疾病组P100比较,NMO组潜伏期显著延长(P<0.05),波幅差异无显著性(P>0.05)。结论:NMO的VEP特点为潜伏期延长为主,伴或不伴波幅下降,严重时波形消失。VEP能够检出r-LETM的亚临床视神经病灶,有助于对NMO的早期诊断。 Objective To investigate the significance of visual evoked potential(VEP) in patients with neuromyelitis optica(NMO) or relapse-longitudinally extensive transverse myelitis(r-LETM).Methods The VEP were examined in 16 inpatients with NMO and 15 inpatients with r-LETM,and the results were compared with those from normal control group.Results The latency of P100 in NMO group was significantly longer than that in control group,and the amplitude was decreased significantly in NMO group(all P 0.05);the abnormal rate of latency was higher than that of amplitude.The P100 amplitude was significantly lower in r-LETM group than that in control group(P 0.05),while no significant difference was found in P100 latency between the two groups(P 0.05);the abnormal rate of amplitude was higher than that of latency.The latency was significantly longer in NMO group than that in r-LETM group(P 0.05),but no significant difference was found in amplitude between the two groups(P 0.05).Conclusions The VEP in NMO was characterized as prolonged latency with or without reduction of amplitude,and wave could disappeared in a badly condition.VEP could help to detect sub-clinical optic nerve damage of r-LETM,which might be helpful in the early diagnosis of NMO.
出处 《实用医学杂志》 CAS 北大核心 2013年第10期1585-1587,共3页 The Journal of Practical Medicine
基金 国家自然科学基金资助项目(编号:30800356) 天津市自然科学基金资助项目(编号:07JCYBJC16200) 教育部留学回国人员科研启动基金资助项目(编号:教外司留[2008]第890号) 天津医科大学总医院引进人才科研启动基金资助项目
关键词 视神经脊髓炎 复发性长节段横贯性脊髓炎 视觉诱发电位 Neuromyelitis optica Relapse-longitudinally extensive transverse myelitis Visual evoked potential
  • 相关文献

参考文献8

  • 1Wingerchuk D M, Lennon V A, Pittock S J, etal. The spectrum of neuromyelitis optica [J]. Lancet Neurol, 2007, 6 (9) : 805-815.
  • 2Wingerchuk D M, Lennon V A, Pittock S J, et al. Revised diagnostic criteria for neuromyelitis optica [J]. Neurology, 2006, 66(10) : 1485-1489.
  • 3Cabrera-G6mez J A, Saiz-Hinarejos A, Graus F, et al. Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders [J]. Multiple Sclerosis, 2008, 14(2): 248-251.
  • 4陈彧,赵建民,王夏红,何文龙,张慧敏.视觉诱发电位在视神经脊髓炎中的诊断价值[J].中国实用神经疾病杂志,2008,11(9):48-50. 被引量:3
  • 5Nero S P, Alvarenga R M, Vasconcelos C C, et al. Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica [J]. Multiple Sclerosis, 2012, 19(2): 173-178.
  • 6Matthews W B, Small D G, Small M, et al. Pattern reversal evoked visual potential in the diagnosis of multiple sclerosis [J]. Neurol Neurosurg Psychiatry, 1977, 40(10): 1009-1014.
  • 7Niklas A, Sebraoui H, Hess E, et aL Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency [J]. Muhiple Sclerosis, 2009, 15(1) : 68-74.
  • 8潘映辐.临床诱发电位学[M]2版[M].北京:人民卫生出版社,1999.147-9.

二级参考文献3

  • 1[1]Odom JV,Bach M,Barber C,et al.Visual evoked potentials standard (2004)[J].Doc Ophthalmol,2004,108(2):115-123.
  • 2[2]Wingerchuk DM,Lennon VA,Pittock SJ,et al.Revised diagnostic criteria for neuromyelitis optica[J].Neurology,2006,66(10):1485-1489.
  • 3[3]Wingerchuk DM.Neuromyelitis optica[J].Int MS J,2006,13(2):42-50.

共引文献10

同被引文献24

  • 1何晓非,郭端,周红雨,周华勇.视神经脊髓炎临床特征分析[J].四川大学学报(医学版),2010,41(5):919-921. 被引量:3
  • 2Huh SY, Kim SH, Hyun JW, et al. Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder[J]. JAMA Neurol, 2014, 71(11): 1372-1378.
  • 3LENNON VA, WINGERCHUK DM, KRYZER TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis [J]. Lancet, 2004, 364(9451): 2106- 2112.
  • 4JARIUS S, WILDEMANN B. Effect of storage conditions and freeze/thaw cycles on aquaporin-4 antibody (NMO-IgG) serum levels [J]. Clin Chem Lab Med, 2011, 49(12) : 2121-2122.
  • 5WINGERCHUK DM, BANWELL B, BENNETT JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders [J]. Neurology, 2015, 85 (2): 177- 189.
  • 6LONG Y, QIU W, LU Z, et al. Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica [J]. Neuroimmunomodulation, 2012, 19(2) : 96-102.
  • 7ROEMER SF, PARISI JE, LENNON VA, et al. Patteru- specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis [J]. Brain, 2007, 130(Pt 5) : 1194-1205.
  • 8MISU T, HOFTBERGER R, FUJIHARA K, et al. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica [J]. Acta Neuropathol, 2013, 125 (6) : 815-827.
  • 9ASAVAPANUMAS N, RATELADE J, VERKMAN AS. Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG [J].Acta Neuropathol, 2014, 127(4): 539-551.
  • 10SAIKALI P, CAYROL R, VINCENT T. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica [J]. Autoimmun Rev, 2009, 9(2) : 132-135.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部